Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05008419 · ClinicalTrials.gov registry record · NA

Narrative Discourse Treatment Development

A NA study of Traumatic Brain Injury and Neurogenic Communication Disorders, sponsored by VA Office of Research and Development.

Active
Registry status
NA
Development phase
34
Enrollment target
1
Study location

NCT05008419 is a NA study of Traumatic Brain Injury and Neurogenic Communication Disorders that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 34 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05008419, a NA study of Traumatic Brain Injury and Neurogenic Communication Disorders, is active but no longer recruiting, sponsored by VA Office of Research and Development.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

Discourse impairments are breakdowns in meaningful communication beyond the level of single sentences and have a functional impact on the lives of Veterans with TBI, disrupting return to work, communication re integration, socialization, and quality of life. The few prior attempts to treat discourse impairments have been small case studies and resulted in no change or limited gains. The proposed study evaluates the feasibility of a novel narrative discourse treatment that builds upon these prior attempts by addressing breakdowns in both story content and story organization using a theoretically-driven approach. If feasible, as demonstrated by tolerability and acceptability to participants, and later shown to be effective, the proposed discourse treatment has the potential to improve daily communication, which provides a gateway for Veterans with TBI to increase meaningful participation and improve functioning in major life domains.

Conditions Studied

Traumatic Brain Injury Neurogenic Communication Disorders

Interventions

  • BEHAVIORAL Narrative discourse treatment

Study Locations (1)

Connecticut

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2023-11-27
Est. Completion 2026-09-30
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05008419

The ClinicalTrials.gov registry entry for NCT05008419 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (88% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which Narrative discourse treatment is the first listed.

NCT05008419 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT05008419 about?

NCT05008419 is a clinical study titled "Narrative Discourse Treatment Development". Discourse impairments are breakdowns in meaningful communication beyond the level of single sentences and have a functional impact on the lives of Veterans with TBI, disrupting return to work, communication re integration, socialization, and quality of life. The few prior attempts to treat discourse...

What is the current status of trial NCT05008419?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2023-11-27. Estimated completion is 2026-09-30.

What conditions does trial NCT05008419 study?

This clinical trial studies the following conditions: Traumatic Brain Injury, Neurogenic Communication Disorders.

What interventions are being tested in trial NCT05008419?

The interventions under investigation include: Narrative discourse treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT05008419?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05008419 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Traumatic Brain Injury

All registered trials for this condition

Neurogenic Communication Disorders

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.